Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Clinical Pharmacology and Therapeutics
|
August 1, 1996
Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes
C Y Tseng, S L Wang, M D Lai, et al.
Anticancer Research
|
November 1, 1996
K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers
J C Lee, S T Wang, M D Lai, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Propranolol disposition in Chinese subjects of different CYP2D6 genotypes
M L Lai, S L Wang, M D Lai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 1, 1995
Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections
J C Lee, P W Lin, Y J Lin, et al.
Pharmacogenetics
|
February 18, 1999
The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population
H J Su, Y L Guo, M D Lai, et al.
British Journal of Cancer
|
June 5, 2003
Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5
J-L Hsieh, C-L Wu, M-D Lai, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1993
Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence
J N Yuan, B H Liu, H Lee, et al.
Anticancer Research
|
September 1, 1996
Expression pattern of nuclear p53 is unique in COS-1 cells
J C Lee, T S Lee, H Y Ho, et al.
Biochemistry
|
May 25, 1982
Role of aromatic residues in the structure-function relationship of alpha-bungarotoxin
Y H Chen, J C Tai, W J Huang, et al.
Molecular Carcinogenesis
|
July 1, 1995
Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines
Y T Cheng, Y L Li, J D Wu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Clinical Pharmacology and Therapeutics
|
August 1, 1996
Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes
C Y Tseng, S L Wang, M D Lai, et al.
Anticancer Research
|
November 1, 1996
K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers
J C Lee, S T Wang, M D Lai, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Propranolol disposition in Chinese subjects of different CYP2D6 genotypes
M L Lai, S L Wang, M D Lai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 1, 1995
Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections
J C Lee, P W Lin, Y J Lin, et al.
Pharmacogenetics
|
February 18, 1999
The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population
H J Su, Y L Guo, M D Lai, et al.
British Journal of Cancer
|
June 5, 2003
Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5
J-L Hsieh, C-L Wu, M-D Lai, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1993
Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence
J N Yuan, B H Liu, H Lee, et al.
Anticancer Research
|
September 1, 1996
Expression pattern of nuclear p53 is unique in COS-1 cells
J C Lee, T S Lee, H Y Ho, et al.
Biochemistry
|
May 25, 1982
Role of aromatic residues in the structure-function relationship of alpha-bungarotoxin
Y H Chen, J C Tai, W J Huang, et al.
Molecular Carcinogenesis
|
July 1, 1995
Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines
Y T Cheng, Y L Li, J D Wu, et al.
Page
of 6